FDA 483 - Solvias AG - September 01, 2023

During an inspection, Solvias AG, a Contract Research Organization in Kaiseraugst, Switzerland, was cited for issues related to data integrity in method validation. The firm rejected and repeated precision and accuracy data without proper justification. Specifically, a claimed dilution error used to justify retesting was not documented in the sample preparation records.